It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …

The development of human papillomavirus (HPV) vaccines has made substantive progress,
as represented by the approval of five prophylactic vaccines since 2006. Generally, the …

Despite the development of highly effective prophylactic vaccines against human
papillomavirus (HPV) serotypes 16 and 18, prevention of cervical dysplasia and cancer in …

Background: Vulval intraepithelial neoplasia (VIN) is a premalignant condition, which is
frequently associated with type HPV16 infection, and multifocal disease has high rates of …

Due to their rapid and widespread development, DNA vaccines have entered into a variety
of human clinical trials for vaccines against various diseases including cancer. Evidence that …

Licensed human papillomavirus (HPV) vaccines contain virus-like particles (VLPs) self-
assembled from L1 major-capsid proteins that are remarkably effective prophylactic …

Heat-shock proteins (HSPs) have been known as multifunctional proteins. They facilitate the
folding and unfolding of proteins, participate in vesicular transport processes, prevent …

High prevalence of squamous anal lesions is linked to oncogenic human papillomavirus
(HPV). Human immunodeficiency virus (HIV) promotes anal carcinogenesis. Epidermal …

It is now well established that most cervical cancers are causally associated with HPV
infection. This realization has led to efforts to control HPV-associated malignancy through …

Infections with sexually transmitted high-risk Human Papillomavirus (hrHPV), of which there
are at least 15 genotypes, are responsible for a tremendous disease burden by causing …